Cargando…
Progressive vitiligo induced by recurrent melanoma
A woman had undergone excision for primary melanoma of the left heel and dissection of groin lymph nodes. The recurrent tumor on the lateral left lower leg developed six months ago and the depigmented plaques spread extensively on the left lower limb. The depigmented macules were localized to the le...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762551/ https://www.ncbi.nlm.nih.gov/pubmed/35070306 http://dx.doi.org/10.1002/ccr3.5290 |
_version_ | 1784633787585396736 |
---|---|
author | Nakai, Yasuo Ueki, Ayaka Yamanaka, Keiichi |
author_facet | Nakai, Yasuo Ueki, Ayaka Yamanaka, Keiichi |
author_sort | Nakai, Yasuo |
collection | PubMed |
description | A woman had undergone excision for primary melanoma of the left heel and dissection of groin lymph nodes. The recurrent tumor on the lateral left lower leg developed six months ago and the depigmented plaques spread extensively on the left lower limb. The depigmented macules were localized to the left lower limb and were not seen in other areas. Although the left groin lymph node had been dissected, the local immune environment of anti‐tumor immunity was preserved. The cause of melanoma‐associated vitiligo is regarded to be anti‐tumor autoimmune mediated, and this phenomenon is recently recognized during the therapy with immune checkpoint inhibitors in the treatment of stage III and IV melanoma |
format | Online Article Text |
id | pubmed-8762551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87625512022-01-21 Progressive vitiligo induced by recurrent melanoma Nakai, Yasuo Ueki, Ayaka Yamanaka, Keiichi Clin Case Rep Clinical Images A woman had undergone excision for primary melanoma of the left heel and dissection of groin lymph nodes. The recurrent tumor on the lateral left lower leg developed six months ago and the depigmented plaques spread extensively on the left lower limb. The depigmented macules were localized to the left lower limb and were not seen in other areas. Although the left groin lymph node had been dissected, the local immune environment of anti‐tumor immunity was preserved. The cause of melanoma‐associated vitiligo is regarded to be anti‐tumor autoimmune mediated, and this phenomenon is recently recognized during the therapy with immune checkpoint inhibitors in the treatment of stage III and IV melanoma John Wiley and Sons Inc. 2022-01-17 /pmc/articles/PMC8762551/ /pubmed/35070306 http://dx.doi.org/10.1002/ccr3.5290 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Images Nakai, Yasuo Ueki, Ayaka Yamanaka, Keiichi Progressive vitiligo induced by recurrent melanoma |
title | Progressive vitiligo induced by recurrent melanoma |
title_full | Progressive vitiligo induced by recurrent melanoma |
title_fullStr | Progressive vitiligo induced by recurrent melanoma |
title_full_unstemmed | Progressive vitiligo induced by recurrent melanoma |
title_short | Progressive vitiligo induced by recurrent melanoma |
title_sort | progressive vitiligo induced by recurrent melanoma |
topic | Clinical Images |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762551/ https://www.ncbi.nlm.nih.gov/pubmed/35070306 http://dx.doi.org/10.1002/ccr3.5290 |
work_keys_str_mv | AT nakaiyasuo progressivevitiligoinducedbyrecurrentmelanoma AT uekiayaka progressivevitiligoinducedbyrecurrentmelanoma AT yamanakakeiichi progressivevitiligoinducedbyrecurrentmelanoma |